Mass Spectrometry as a Tool for Metabolomics in Cancer
Advances in Experimental Medicine and Biology · 2026 · 525-554
DOI: 10.1007/978-3-032-12166-0_19 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Experimental Medicine and Biology, online erschienen am 12.07.2026. Verfasst von João S Patrício und 3 weiteren Autor:innen. Beteiligte Einrichtung: iNOVA4Health, NOVA Medical School | Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisboa, Portugal. Hauptthemen laut MEDLINE: Metabolomics, Mass Spectrometry, Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 164 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- iNOVA4Health, NOVA Medical School | Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisboa, Portugal.
- iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12,, 2781-901, Oeiras, Portugal.
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República,, 2780-157, Oeiras, Portugal.
- iNOVA4Health, NOVA Medical School | Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisboa, Portugal. judit.morello@nms.unl.pt.
Zitieren
APA
Patrício, J. S., Guerreiro, A. C. L., Gameiro, P. A., & Morello, J. (2026). Mass Spectrometry as a Tool for Metabolomics in Cancer. Advances in Experimental Medicine and Biology, 525-554. https://doi.org/10.1007/978-3-032-12166-0_19
Vancouver
Patrício JS, Guerreiro ACL, Gameiro PA, Morello J. Mass Spectrometry as a Tool for Metabolomics in Cancer. Advances in Experimental Medicine and Biology. 2026:525-554. doi:10.1007/978-3-032-12166-0_19
BibTeX
@article{Patrcio2026,
author = {Patrício, João S and Guerreiro, Ana C L and Gameiro, Paulo A and Morello, Judit},
title = {Mass Spectrometry as a Tool for Metabolomics in Cancer},
journal = {Advances in Experimental Medicine and Biology},
year = {2026},
pages = {525--554},
doi = {10.1007/978-3-032-12166-0_19}
}
EUVIMED